Suchergebnisse - (Subject:"coronavirus")

PubPharm (74.039)

51

Development and validation of a predicting nomogram for in-hospital mortality of COVID-19 Omicron variant : A cohort study of 1324 cases in Beijing Anzhen Hospital

enthalten in: Heliyon | 2024

von Shi, Y. | Ma, Y. | Zheng, Z. | +3

52

Effectiveness and safety of immune response to SARS‑CoV‑2 vaccine in patients with chronic kidney disease and dialysis : A systematic review and meta‑analysis

enthalten in: Biomedical reports | 2024

von Li, K. | Xia, Y. | Ye, H. | +3

53

Three years into the pandemic : Insights of the COVID-19 impacts on food security and nutrition in low and middle-income countries

enthalten in: Heliyon | 2024

von Ben Hassen, T. | El Bilali, H.

54

Capturing the emotional and social experiences of COVID-19 through journal entries : A qualitative study of COVID-19 experiences over six weeks following infection

enthalten in: Heliyon | 2024

von Kenton, N. | Gronowski, B. | Fish, D. | +2

55

Prevalence and clinical impact of mono- and co-infections with endemic coronaviruses 229E, OC43, NL63, and HKU-1 during the COVID-19 pandemic

enthalten in: Heliyon | 2024

von Trifonova, I. | Korsun, N. | Madzharova, I. | +8

56

Impact of coronavirus pandemic on stock index : A polynomial regression with time delay

enthalten in: Heliyon | 2024

von Bowen, D.

57

SARS-CoV-2 associated unilateral parotitis in children : A case report and literature review

enthalten in: Biomedical reports | 2024

von Marino, A. | Cacciaguerra, G. | Spampinato, S. | +7

58

The safety, quality evaluation, and lot release of COVID-19 vaccines imported and used in Nigeria from march 2021 to march 2022

enthalten in: Discover Health Systems | 2024

von Kanu, N. | Adeyeye, C. | Abiola, V. | +4

59

Nanoengineered Red Blood Cells Loaded with TMPRSS2 and Cathepsin L Inhibitors Block SARS-CoV-2 Pseudovirus Entry into Lung ACE2+ Cells

enthalten in: Advanced materials (Deerfield Beach, Fla.) | 2024

von Yang, H. | Zhou, J. | Zhang, X. | +15

60

Molecular modelling studies and in vitro enzymatic assays identified A 4-(nitrobenzyl)guanidine derivative as inhibitor of SARS-CoV-2 Mpro

enthalten in: Scientific reports | 2024

von de Santiago-Silva, K. | Camargo, P. | Carvalho Constant, L. | +6